MACQUARIE GROUP LTD - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 179 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$80,000
+19.4%
5,019
-20.6%
0.00%
Q2 2022$67,000
-35.0%
6,3210.0%0.00%
Q1 2022$103,000
-10.4%
6,321
-23.9%
0.00%
Q4 2021$115,000
+23.7%
8,305
+27.7%
0.00%
Q3 2021$93,000
-31.6%
6,502
-24.4%
0.00%
Q2 2021$136,000
+60.0%
8,605
+3.0%
0.00%
Q1 2021$85,000
+14.9%
8,352
-15.9%
0.00%
Q4 2020$74,000
+117.6%
9,9320.0%0.00%
Q3 2020$34,000
+6.2%
9,932
+47.5%
0.00%
Q2 2020$32,000
+255.6%
6,732
+274.0%
0.00%
Q4 2017$9,000
-87.5%
1,800
-92.9%
0.00%
Q1 2016$72,000
-95.0%
25,529
-81.7%
0.00%
-100.0%
Q4 2015$1,437,000
-8.3%
139,248
+1.3%
0.00%0.0%
Q3 2015$1,567,000
-7.7%
137,442
+21.0%
0.00%0.0%
Q2 2015$1,697,000
+70.2%
113,635
+2.9%
0.00%
+50.0%
Q1 2015$997,000
-42.3%
110,392
-22.4%
0.00%
-50.0%
Q4 2014$1,729,000
+79.4%
142,167
+44.3%
0.00%
+100.0%
Q3 2014$964,000
+121.6%
98,551
+189.0%
0.00%
+100.0%
Q2 2014$435,00034,1000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Burrage Capital Management LLC 1,105,673$8,237,0006.28%
Sarissa Capital Management LP 8,175,000$60,903,0006.22%
ORACLE INVESTMENT MANAGEMENT INC 2,980,870$22,207,0002.78%
DG Capital Management, LLC 1,075,732$8,014,0001.70%
Ghost Tree Capital, LLC 900,000$6,705,0001.49%
Parkman Healthcare Partners LLC 538,370$4,011,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,835,810$43,477,0000.86%
Formidable Asset Management, LLC 470,419$3,470,0000.80%
KNOTT DAVID M 219,461$1,635,0000.74%
Altium Capital Management LP 250,000$1,863,0000.70%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders